Jellagen, an innovative marine biotechnology company was co-founded in 2013 by Professor Andrew Mearns Spragg, a Scottish marine biotechnology pioneer. The idea first came to Andrew whilst surfing off the East coast of Scotland in his youth swimming through blooms of jellyfish.
Due to human activity in the oceans, jellyfish populations are now blooming. The resulting explosion in jellyfish along coastal regions is causing increasing incidents of bathers being stung, off shore aquaculture collapse and in some cases power stations to be shut down due to water inlets becoming clogged.
In the early days, Jellagen operated out of a shed in Tenby but soon moved to the Bridge Innovation Centre at Pembroke Dock. The company continued to develop its business focused on new innovative manufacturing processes and developing new products using collagen derived from jellyfish to provide a next generation collagen biomaterial.
From those early days, Jellagen has taken up additional space at Cardiff’s Capital Business Park where it commissioned the build and installation of a bespoke collagen manufacturing facility and Quality Control laboratory which were officially launched in May 2017
Since 2013, Jellagen has secured considerable investment from both private investors and public sources to develop its business. In 2018, Jellagen has commercialised its jellyfish collagen cell culture products for research, achieved ISO13485 certification for our collagen manufacturing processes and by the end of 2018, the company will employ >12 people.
If populations of jellyfish continue to rise globally we may need to get used to living in a gelatinous world.